- On April 2, 2016
In April of 2015 Governor Nathan Deal signed House Bill 1 also known as Haleigh’s Hope Act into law allowing citizens with very specific and significantly debilitating conditions such as cancer, ALS, Parkinson’s, MS, epilepsy or sickle cell anemia to possess up to 20 ounces of cannabis oil that contains no more than 5% THC. On its face this appears to be major progress for patients whose physicians recommend medicinal cannabis.
Unfortunately, there is a major issue with the law and that is that it is not legal in Georgia to grow cannabis, either low THC varieties or otherwise. That means patients have no way to access the medicine they are legally allowed to possess. The state tells them that they are able to import it from other states that have a legal cannabis program, but doing so would be a violation of Federal Law.
It would stand to reason that when this obvious catch 22 was exposed that the state of Georgia would take remedial measures to fix the issue, but new evidence shows that this is not the case. As it stands today, a patient can possess cannabis oil in Georgia if they have a qualifying condition and have been certified to do so by their physician, they just have no way to procure the oil without committing a Federal felony.
While this may be a tricky situation, we believe it is one that is easily remedied through the production of biosynthetic cannabinoids in a laboratory environment. This is exactly the reason that Tuatara has made an investment in CBC Biotechnologies. Their scientific solutions directly address problems such as these and they do so in a way that should satisfy the Governor’s office and all law enforcement concerns. We look forward to sharing more in the coming months.